Additive and combined glaucoma therapy: principles and practice

Kuroyedov, A.V.; Нагорнова, З. М.; Тибиева, З. У.; Krinitsyna, E.A.; Сергеева, В. М.

doi:10.21516/2072-0076-2018-11-2-71-81

Cited by 7 publications

(2 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…ст. [24]. Разные зарубежные авторы также показали эффективность комбинированной терапии глаукомы в сравнении с монотерапией [25][26][27].…”

Section: результаты и обсуждениеunclassified

“…Ранее авторы указывали на то, что выбор терапии должен зависеть от возраста, клинического типа глаукомы, картины болезни, наличия сопутствующих системных заболеваний, прогнозируемой приверженности назначенному режиму при сохранении достаточного качества жизни. Кроме того, следует учитывать механизм действия препарата, его способность понижать уровень ВГД до определенных значений, состояние глазной поверхности, наличие сопутствующих глазных заболеваний, условия хранения (наличие консерванта) и стоимость лечения [24].…”

Section: результаты и обсуждениеunclassified

See 1 more Smart Citation

Features of Monitoring Patients with Primary and Advanced Stages of Glaucoma in Krasnodar Territory

Апостолова¹,

Малышев²,

Гурджиян³

et al. 2020

Oftalʹmologiâ

View full text Add to dashboard Cite

Purpose: to analyze the monitoring of patients with primary and advanced stages of glaucoma, who applied to the private clinic “Tri-Z” (Krasnodar).Patients and Methods. A total of 3 524 patients underwent screening with a diagnosis of glaucoma for all over 2018 at the clinic, of which 55.6 % were diagnosed with primary and advanced glaucoma. The criterion for inclusion in the study was primary glaucoma of the initial and advanced stages, elimination criteria: high degree of refraction errors, retinal detachment in anamnesis, proliferative diabetic retinopathy, AMD exudative forms, congenital forms of glaucoma, secondary types of glaucoma.Results: The average age of patients was 68.44 ± 8.142 years, women were 71 %, men — 29 %. The average duration of glaucomatous history was 3.48 ± 3.525 years. POAG was found in 85.3 % of cases, PACG in 14.7 % of cases. Glaucoma without concomitant PEX was observed in 44.7 % cases, with signs of PEX in 55.3 % cases. In stage I of glaucoma, the majority of patients (42.7 %) received APG and in 27.1 % cases a fixed combination of ICA + BB. In stage II glaucoma, the majority of patients (26.5 %) received a fixed combination of ICA + BB, in 18.8 % of cases, the combination of APG + ICA + BB and in 17.7 % — APG. The share of laser interventions: LTP — 14.7 %, SLT — 4.1 %, peripheral iridectomy — 10 %, YAG-GP — 0.8 %, SLT + YAG-GP — 0.8 %, peripheral iridectomy + SLT — 0.5 %. The share of surgical interventions: at glaucoma stage I non-penetrating deep sclerectomy (NPDS) — 3.4 %; at stage II NPDS — 10.9 %, repeated NPDS — 0.5 %, deepsclerectomy — 2.2 %; phacoemulsification + IOL — 21.9 % of cases.Conclusion: In the study, we noted the following features: use, including as a starting therapy, effective drugs or their combinations; the preferred use of fixed combinations; prioritization of non-preservative therapy; high frequency of laser interventions in the anterior eye segment; use of peripheral laser iridectomy in the overwhelming majority of cases when PACG is detected; early transition to surgical treatment.

show abstract